DFG-funded HyperMet research unit: Start of Silke Jost as HyperMet science officer and Moritz Eggelbusch as postdoc in HyperMet

1 March 2025 marked the start of the DFG-funded HyperMet research unit (2 x 4 years), which is headed by Henning Wackerhage (TUM Sports Biology) and Hanna Taipaleenmäki (LMU). On 1 March, Silke Jost also started as HyperMet Science Officer and Moritz Eggelbusch as HyperMet Postdoc in Sports Biology. The research group aims to investigate the effects of muscle hypertrophy and atrophy on metabolic health.

Silke Jost has a doctorate in biochemistry. She will support the research group as science officer and oversee events, finances, strategy and social media.

Moritz Eggelbusch studied sports science at the University of Münster and completed his doctorate at the Vrije Universiteit Amsterdam in Rob Wüst's group. In his dissertation, he researched the metabolic links between immobility, inflammation and skeletal muscle atrophy, and was honoured for his work with the John O. Holloszy Young Investigator Award from the International Research Group on Biochemistry of Exercise. Within the HyperMet project, Moritz will investigate how hypertrophying and atrophying muscles change their metabolism and what effects these changes have on the overall metabolism of the organism.

HyperMet research examines the impact of muscle growth (hypertrophy) and muscle loss (atrophy) on metabolism. Increased muscle mass reduces the risk of obesity, diabetes, osteoporosis, and potentially cancer. We are exploring the underlying metabolic processes to develop new strategies for prevention and everyday life.